erythromycin has been researched along with vasoactive intestinal peptide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goswami, SK; Marom, ZM | 1 |
Fiorucci, S; Morelli, A | 1 |
Ji, M; Lin, L; Lin, Z; Zhang, HJ; Zhao, ZQ | 1 |
Badran, B; El Zein, N; Sariban, E | 1 |
4 other study(ies) available for erythromycin and vasoactive intestinal peptide
Article | Year |
---|---|
Respiratory mucus hypersecretion (bronchorrhea): a case discussion--possible mechanisms(s) and treatment.
Topics: Aged; Bronchial Diseases; Enzyme-Linked Immunosorbent Assay; Erythromycin; Humans; Lung; Male; Mucus; Parasympathetic Nervous System; Vasoactive Intestinal Peptide | 1991 |
Motilin and erythromycin stimulate pepsinogen secretion by chief cells isolated from guinea pig stomach.
Topics: Animals; Atropine; Calcium; Carbachol; Cholecystokinin; Dinoprostone; Erythromycin; Gastric Mucosa; Guinea Pigs; In Vitro Techniques; Kinetics; Male; Motilin; Pepsinogens; Secretin; Vasoactive Intestinal Peptide | 1993 |
Effect of erythromycin on gastric dysmotility and neuroendocrine peptides in rats with diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Male; Motilin; Muscle Contraction; Muscle, Smooth; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2005 |
VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.
Topics: Acetylcysteine; Animals; Calcium; CD18 Antigens; Cell Line; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Erythromycin; Humans; Matrix Metalloproteinase 9; Monocytes; Neutrophils; Polymerase Chain Reaction; Receptors, Complement 3b; Receptors, Formyl Peptide; Receptors, Lipoxin; Receptors, Vasoactive Intestinal Polypeptide, Type I; Signal Transduction; Transfection; Vasoactive Intestinal Peptide | 2008 |